[{"NetIncomeLoss_1_Q2_USD":35011000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":329918000.0,"PaymentsToAcquireInvestments_2_Q2_USD":8355000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":3725000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":2513000.0,"PaymentsToAcquireOtherPropertyPlantAndEquipment_2_Q2_USD":18536000.0,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":1106000.0,"AssetsCurrent_0_Q2_USD":752313000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GeneralAndAdministrativeExpense_2_Q2_USD":137484000.0,"MalpracticeLossContingencyAccrualUndiscountedCurrent_0_Q2_USD":36473000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":6000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":14000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q2_USD":0.05,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2_Q2_USD":0.2,"GeneralAndAdministrativeExpense_1_Q2_USD":70968000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":993000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1021000.0,"OtherNoncashIncomeExpense_2_Q2_USD":1205000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":2578000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ProceedsFromSaleOfOtherPropertyPlantAndEquipment_2_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":9452000.0,"Assets_0_Q2_USD":2555130000.0,"CommonStockSharesIssued_0_Q2_shares":86337000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1536000.0,"AvailableForSaleSecurities_0_Q2_USD":100763000.0,"AccruedSalariesCurrent_0_Q2_USD":129915000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":13000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":15000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":1152440000.0,"RestructuringCharges_1_Q2_USD":9932000.0,"RestructuringCharges_2_Q2_USD":14810000.0,"StockRepurchasedDuringPeriodShares_2_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":116000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":56329000.0,"Liabilities_0_Q2_USD":1746006000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":10745000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":7363000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2408000.0,"RepaymentsOfSeniorDebt_2_Q2_USD":759848000.0,"AccountsReceivableNetCurrent_0_Q2_USD":248055000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-14532000.0,"PrepaidExpenseCurrent_0_Q2_USD":18896000.0,"CommonStockValue_0_Q2_USD":863000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":85933000.0,"PaymentsOfFinancingCosts_2_Q2_USD":0.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":30527000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":35871000.0,"MinorityInterest_0_Q2_USD":218000.0,"EarningsPerShareBasic_1_Q2_USD":0.41,"EarningsPerShareBasic_2_Q2_USD":0.62,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":85653000.0,"InvestmentIncomeNet_2_Q2_USD":10143000.0,"InvestmentIncomeNet_1_Q2_USD":4176000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":39977000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":338157000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q2_USD":0.05,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_Q2_USD":0.19,"OtherAssetsNoncurrent_0_Q2_USD":114405000.0,"CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_2_Q2_USD":0.0,"OtherAssetsCurrent_0_Q2_USD":17387000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":189000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-760810000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":8106000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":16137000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":0.0,"InterestPayableCurrent_0_Q2_USD":29280000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-54453000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_Q2_USD":-28484000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1039231000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":1859000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":7207000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-28601000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5735000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q2_USD":4478000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_2_Q2_USD":16768000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":37890000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":38279000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":84660000.0,"Goodwill_0_Q2_USD":1487105000.0,"ProceedsFromSaleOfBuildings_2_Q2_USD":24728000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":577000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":1072000.0,"EarningsPerShareDiluted_1_Q2_USD":0.41,"EarningsPerShareDiluted_2_Q2_USD":0.61,"CommonStockSharesOutstanding_0_Q2_shares":85593000.0,"CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2_Q2_USD":2350000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":84912000.0,"LiabilitiesCurrent_0_Q2_USD":351105000.0,"AccountsPayableCurrent_0_Q2_USD":40658000.0,"NetIncomeLoss_2_Q2_USD":52653000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":68481000.0,"NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_Q2_USD":-760810000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":48428000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":19989000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":809124000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.36,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":0.42,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":57923000.0,"InterestExpense_1_Q2_USD":16879000.0,"InterestExpense_2_Q2_USD":34524000.0,"IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_2_Q2_USD":-715000.0,"NonoperatingIncomeExpense_1_Q2_USD":-12126000.0,"NonoperatingIncomeExpense_2_Q2_USD":-37841000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_2_Q2_USD":-117000.0,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_Q2_USD":1375000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":26005000.0,"MalpracticeLossContingencyAccrualUndiscountedNoncurrent_0_Q2_USD":267319000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6400000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2555130000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-17033000.0,"PreferredStockValue_0_Q2_USD":0.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":28165000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5800000.0,"StockRepurchasedDuringPeriodValue_1_Q2_USD":251000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":100763000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":2245000.0,"OperatingIncomeLoss_1_Q2_USD":50016000.0,"OperatingIncomeLoss_2_Q2_USD":76120000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-40800000.0,"IncomeTaxesReceivable_0_Q2_USD":29055000.0,"GainLossOnSaleOfProperties_2_Q2_USD":7280000.0,"GainLossOnSaleOfProperties_1_Q2_USD":7280000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":18848000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-233701000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.36,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":0.42,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":1838000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":919712000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":472959000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-10413000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":904385000.0,"StockholdersEquity_0_Q2_USD":808906000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":2339000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":42534000.0,"ProfitLoss_1_Q2_USD":35005000.0,"ProfitLoss_2_Q2_USD":52639000.0,"OperatingExpenses_1_Q2_USD":422943000.0,"OperatingExpenses_2_Q2_USD":843592000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-785686000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2_Q2_shares":0.0,"Ticker":"MD","CIK":"893949","name":"MEDNAX, INC.","OfficialName":"Mednax Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2069794690.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20210806"}]